"We are doing research on Psoriasis, eczema and depression"
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Eli Lilly and Company
4
Asana BioSciences
2
Bristol-Myers Squibb
2
Janssen Research & Development, LLC
2
AOBiome LLC
1
Adare Pharmaceuticals, Inc.
1
Brigham and Women's Hospital
1
Indivior Inc.
1
Clinical Trials at Unity Clinical Research
During the past decade, Unity Clinical Research conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on
average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7%
of trials that started reached the finish line.
A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
2019-08-12
2026-07-26
Active, not recruiting
1,452
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Unity Clinical Research" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Eli Lilly and Company" with 4 trials
sponsored, "Asana BioSciences" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Janssen Research & Development, LLC"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Unity Clinical Research"
#1 collaborator was "Nektar Therapeutics" with 2 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Unity Clinical Research
According to Clinical.Site data, the most researched conditions in "Unity Clinical Research" are
"Atopic Dermatitis" (5 trials), "Dermatitis, Atopic" (3 trials), "Psoriasis" (3 trials), "Hidradenitis Suppurativa" (2 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Unity Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Unity Clinical Research
Most popular intervention types in "Unity Clinical Research" are "Drug" (16 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Spesolimab" (3 trials), "ASN002" (2 trials), "BMS-986165" (2 trials) and "LY3471851" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Unity Clinical Research
The vast majority of trials in "Unity Clinical Research" are
18 trials for "All" genders.
Clinical Trials Status at Unity Clinical Research
Currently, there are NaN active trials in "Unity Clinical Research".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Unity Clinical Research,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Unity Clinical Research, 2 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".